Liver International

Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease
pp. 1021-1028(8)
Author: Day, C. P.

How to modulate inflammatory cytokines in liver diseases
pp. 1029-1039(11)
Authors: Tilg, Herbert; Kaser, Arthur; Moschen, Alexander R.

Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations
pp. 1040-1046(7)
Authors: Buscarini, Elisabetta; Plauchu, Henry; Garcia Tsao, Guadalupe; White, Robert I.; Sabbà, Carlo; Miller, Franklin; Saurin, Jean Cristophe; Pelage, Jean Pierre; Lesca, Gaetan; Marion, Marie Jeanne; Perna, Annalisa; Faughnan, Marie E.

Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States
pp. 1047-1053(7)
Authors: McLean, Luciana; Patel, Tushar

Quantitative assessment of liver fibrosis: a novel automated image analysis method
pp. 1054-1064(11)
Authors: Matalka, Ismail I.; Al-Jarrah, Omar M.; Manasrah, Toqa M.

Increased expression of Ob-Rb and its relationship with the overexpression of TGF-β1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis
pp. 1065-1071(7)
Authors: Cayón, A.; Crespo, Javier; Mayorga, M.; Guerra, A.; Pons-Romero, F.

Pulmonary blood volume and transit time in cirrhosis: relation to lung function
pp. 1072-1078(7)
Authors: Møller, Søren; Burchardt, Hans; Øgard, Christina G.; Schiødt, Frank V.; Lund, Jens O.

Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response
pp. 1079-1086(8)
Authors: Hung, Chao-Hung; Lee, Chuan-Mo; Lu, Sheng-Nan; Wang, Jing-Houng; Chen, Chien-Hung; Hu, Tsung-Hui; Kee, Kwong-Ming; Chang, Kuo-Chin; Tseng, Po-Lin; Yen, Yi-Hao; Changchien, Chi-Sin

Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases
pp. 1087-1094(8)
Authors: Liu, Chen-Hua; Lin, Jou-Wei; Tsai, Feng-Chiao; Yang, Pei-Ming; Lai, Ming-Yang; Chen, Jun-Herng; Kao, Jia-Horng; Chen, Ding-Shinn

Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection
pp. 1095-1099(5)
Authors: Parise, Edison R.; Oliveira, Ana C.; Figueiredo-Mendes, Cláudio; Lanzoni, Valéria; Martins, João; Nader, Helena; Ferraz, Maria L.

Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C
pp. 1100-1110(11)
Authors: He, Qi; Graham, Camilla S.; Mangoni, Emanuele Durante; Koziel, Margaret James

Zinc is a negative regulator of hepatitis C virus RNA replication
pp. 1111-1118(8)
Authors: Yuasa, Kazuhisa; Naganuma, Atsushi; Sato, Ken; Ikeda, Masanori; Kato, Nobuyuki; Takagi, Hitoshi; Mori, Masatomo

Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis
pp. 1119-1125(7)
Authors: Soresi, M.; Tripi, S.; Franco, V.; Giannitrapani, L.; Alessandri, A.; Rappa, F.; Vuturo, O.; Montalto, G.

Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis
pp. 1126-1137(12)
Authors: Qiang, Hui; Lin, Yong; Zhang, Xin; Zeng, Xin; Shi, Jian; Chen, Yue-Xiang; Yang, Miao-Fang; Han, Ze-Guang; Xie, Wei-Fen

Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation
pp. 1138-1147(10)
Authors: Osawa, Yosuke; Seki, Ekihiro; Adachi, Masayuki; Taura, Kojiro; Kodama, Yuzo; Siegmund, Soren V.; Schwabe, Robert F.; Brenner, David A.

Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C
pp. 1148-1154(7)
Authors: Paraná, Raymundo; Schinoni, Maria Isabel; de Freitas, Luiz A. R.; Codes, Liana; Cruz, Marla; Andrade, Zilton; Trepo, Christian

Redefining reference limits needs more attention to the analytical aspects
pp. 1155-1156(2)
Authors: CERIOTTI, FERRUCCIO; SCHUMANN, GERHARD; PANTEGHINI, MAURO

Announcements
pp. 1157-1157(1)